Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-049425

President sold 25,000 shares at an average $92.62 ($2,315,578)

  • President acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-09-01 Option exercise +3,933 $14.00 $55,062 651,940 D
Novak Rodger President 2020-09-01 Option exercise +21,067 $14.43 $303,997 673,007 D
Novak Rodger President 2020-09-01 Sale −1,406 $91.54 $128,705 671,601 D
Novak Rodger President 2020-09-01 Sale −19,754 $92.59 $1,829,023 651,847 D
Novak Rodger President 2020-09-01 Sale −3,840 $93.19 $357,850 648,007 D
Derivatives
Novak Rodger President 2020-09-01 Option exercise · Stock Option (Right to Buy) −3,933 111,893 D
Novak Rodger President 2020-09-01 Option exercise · Stock Option (Right to Buy) −21,067 215,315 D
Open-market sales · 25,000 sh · avg $92.62 · $2,315,578
Loading xslF345X03/doc4.xml…